Impact on early and late mortality after blood transfusion in coronary artery bypass graft surgery;Impacto na mortalidade precoce e tardia após transfusão de hemácias em cirurgia de revascularização miocárdica

Brazilian Journal of Cardiovascular Surgery

Volumn 28, Issue 1, 2013, Pages 1-9

  dos Santos, Antonio Alceu ^a   Sousa, Alexandre Gonçalves ^b   de Souza Thomé, Hugo Oliveira ^c   Machado, Roberta Longo ^d   Piotto, Raquel Ferrari ^e  

^a Brazilian Medical Association   (Brazil)

^b Medical Research Center of the Hospital of Charity of St Paul Portuguese   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d Brazilian Association of Intensive Care Medicine (AMIB)   (Brazil)

^e Laboratory of Molecular Biology Division of Dermatology Clinical Hospital of Ribeirão Preto   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BLOOD TRANSFUSION; BRAZIL; CORONARY ARTERY BYPASS GRAFT; EPIDEMIOLOGY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; TIME;

AGE FACTORS; AGED; BLOOD TRANSFUSION; BRAZIL; CORONARY ARTERY BYPASS; EPIDEMIOLOGIC METHODS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84878575754     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.5935/1678-9741.20130003     Document Type: Article

References (29)

1. Boletin de Hemovigilância No 2-ANVISA-2009; P:7. Accessed in 01/July/2012: http://portal.anvisa.gov.br/wps/wcm/connect/3a17a980474585998f47df3fbc4c6735/boletim_hemo_2009.pdf?MOD=AJPERES.
2. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996;84(3):732-747.
3. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105(1):198-208.
4. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al; American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice Management Workgroup. Crit Care Med. 2009;37(12):3124-3157.
5. Bennett-Guerrero E, Zhao Y, O'Brien SM, Ferguson TB Jr, Peterson ED, Gammie JS, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304(14):1568-1575.
6. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544-2552.
7. Dorneles CC, Bodanese LC, Guaragna JCVC, Macagnan FE, Coelho JC, Borges AP, et al. O impacto da hemotransfusão namorbimortalidade pós-operatória de cirurgias cardíacas. Rev Bras Cir Cardiovasc. 2011;26(2):222-229.
8. Silverman RH, Nguyen C, Weight CJ, Klein EA. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol. 2010;7(7):392-402.
9. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49(Suppl 2):1S-29S.
10. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620-624.
11. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011;114(2):283-292.
12. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74(4):1180-1186.
13. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81(5):1650-1657.
14. Novaretti MCZ. Importância dos carreadores de oxigênio livre de células. Rev Bras Hematol Hemoter. 2007;29(4):394-405.
15. Sojka BN, Sojka P. The blood donation experience: self-reported motives and obstacles for donating blood. Vox Sang. 2008;94(1):56-63.
16. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-1567.
17. Hosmer Jr. DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons;1989. p.307.
18. Berkow R, Fletcher AJ, Bondy PK, Faling LJ, Feinstein AR, Frenkel EP, et al. Transfusão de sangue. Manual Merck. 15a ed. 1987:p.1246.
19. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002;9(5):389-395.
20. Spiess BD. Red cell transfusions and guidelines: work in progress. Hematol Oncol Clin North Am. 2007;21(1):185-200.
21. Moraes Neto F, Duarte C, Cardoso E, Tenório E, Pereira V, Lampreia D, et al. Avaliação do EuroSCORE como preditor de mortalidade em cirurgia de revascularização miocárdica no Instituto do Coração de Pernambuco. Rev Bras Cir Cardiovasc. 2006;21(1):29-34.
22. Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;27(4):592-598.
23. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest. 1999;115(6):1598-1603.
24. Senay S, Toraman F, Karabulut H, Alhan C. Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients. Perfusion. 2009;24(6):373-380.
25. Souza DD, Braile DM. Avaliação de nova técnica de hemoconcentração e da necessidade de transfusão de hemoderivados em pacientes submetidos à cirurgia cardíaca com circulação extracorpórea. Rev Bras Cir Cardiovasc. 2004;19(3):287-294.
26. Benfatti RA, Carli AF, Silva GVR, Dias AEMAS, Goldiano JA, Pontes JCDV. Influência do ácido épsilon aminocapróico no sangramento e na hemotransfusão pós-operatória em cirurgia valvar mitral. Rev Bras Cir Cardiovasc. 2010;25(4):510-515.
27. Souza HJB, Moitinho RF. Estratégias para redução do uso de hemoderivados em cirurgia cardiovascular. Rev Bras Cir Cardiovasc. 2008;23(1):53-59.
28. Van der Linden P, Dierick A. Blood conservation strategies in cardiac surgery. Vox Sang. 2007;92(2):103-112.
29. Moskowitz DM, McCullough JN, Shander A, Klein JJ, Bodian CA, Goldweit RS, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg. 2010;90(2):451-458.